anti-CTLA4-TGFbRIIecd

N/A

Report date: 2025/03/14 16:55:32

Base Information

Drug Nameanti-CTLA4-TGFbRIIecd
Drug Alias NameTreg modulator (Johns Hopkins University/Y-Trap)a-CTLA4-TGFbRIIecddual CTLA-4 checkpoint inhibitor/TGFb inhibitor (Johns Hopkins University/Y-Trap)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTransforming growth factor beta inhibitorsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Transforming growth factor beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesY-Trap IncJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A